ATH 25.0% 0.3¢ alterity therapeutics limited

Yes they are starting a phase 1 trial and then following with...

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    Yes they are starting a phase 1 trial and then following with trying to get approval for another. I kind of felt from his body language when he discussed this that there might be some safety concerns and I agree they are so far away. We have going on two years of safety data for PBT2. Like Shoulson kept saying don't underestimate the importance of the safety record (he said something like that).
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.